Tag Archives: Sabin Vaccine Institute

Oct. 6, 1956: Sabin Polio Vaccine Ready to Test

On this day in 1956, the Sabin Polio Vaccine was ready for mass testing. Developed by Dr. Albert B. Sabin, the live-virus oral polio vaccine would eventually help bring an end to the polio epidemic that ran rampant in America during the early 20th century. Below is an excerpt from Wired magazine’s blog, “This Day in Tech” which showcases Dr. Sabin and his revolutionary polio vaccine, take a look:

1956: Dr. Albert Sabin announces that his live-virus oral polio vaccine is ready for mass testing. It will soon supplant the Salk vaccine.

Poliomyelitis is an infectious disease caused by viruses. Its effects range from complete recovery to death. Intermediate possibilities are mild after-effects, moderate to severe paralysis of a limb or limbs, or paralyzed chest muscles, necessitating the confining but lifesaving use of an iron lung.

Polio epidemics periodically ravaged American cities in the first half of the 20th century. Children were especially vulnerable, but the disease also struck adults, most notably former Assistant Secretary of the Navy Franklin D. Roosevelt in 1921.

Roosevelt was elected president in 1932, and he founded the National Foundation for Infantile Paralysis (as the disease was then often called) in 1938. The foundation conducted a huge annual fundraising campaign called the March of Dimes.”

Click hereto read the full blogpost.

Dr. Peter Hotez Awarded for Excellence in Inter-American Public Health

Photo credit:

We are proud to announce that Dr. Peter Hotez, president of the Sabin Vaccine Institute, is the 2011 recipient of the Abraham Horwitz Award for Excellence in Inter-American Public Health.  Awarded by the Pan American Health and Education Foundation (PAHEF) and the Pan American Health Organization (PAHO), the Horwitz Award recognizes Dr. Hotez for his dedication to improving the lives of the impoverished and his tireless work in public health within the Americas.

Dr. Peter Hotez receives the prestige Horwitz Award

This award’s recognition of Dr. Hotez showcases the great progress being made in neglected tropical disease research, advocacy and prevention, but there is still much work to be done in our efforts to end the neglect. Check out the full press release below:

Pioneering scientist Dr. Peter Hotez wins major award for Excellence in Inter-American Public Health

The Abraham Horwitz award will honor Dr. Hotez’s extensive work in global health over the past 30 years

WASHINGTON, D.C.-Sept. 26, 2011- Dr. Peter Hotez, president of the Sabin Vaccine Institute, was honored today with the prestigious Abraham Horwitz Award for Excellence in Inter-American Public Health.  The annual award, presented jointly by the Pan American Health and Education Foundation (PAHEF) and the Pan American Health Organization (PAHO), recognized the major public health contributions that Hotez has made to improve the lives of people living in the Americas. Continue reading

Dr. Peter Hotez Interviewed on VOA News

Earlier this week, Sabin Vaccine Institute President Dr. Peter Hotez was interviewed by Voice of America. The interview focused on NTDs in Sub-Saharan Africa. Dr. Hotez, who is also President of the American Society of Tropical Medicine and Hygiene, shares shocking statistics such as an estimated 400 million people in Sub-Saharan Africa are affected by schistosomiasis and 200 million people within the same region are affected by hookworm infection; more often than not, these individuals make up the half billion people in the continent of Africa who live below the poverty line, grouping these infections into diseases of poverty.

There is hope — Dr. Hotez states that solutions such as mass drug administration, rapid impact packages, and new innovations in vaccines can reduce the prevalence of NTDs, and lead to the eradication of such diseases as lymphatic filariasis, onchocerciasis, and guinea worm. Take a look at the video to learn more:

Sabin Vaccine Institute Announces the Election of Four New Members to Board of Trustees

Washington, DCJuLY 14, 2011The Sabin Vaccine Institute (Sabin) is pleased to announce the election of Baroness Helene Hayman, Gary Rosenthal, Marc Shapiro, and Alisa Swidler to the organization’s Board of Trustees.

“We are honored to have such distinguished individuals join the Sabin Board,” said Morton Hyman, Chairman of the Board of Trustees. “We appreciate their trust and confidence in the Institute and their commitment to our mission to treat and, where feasible, eliminate the diseases that afflict the world’s poorest people. Their contributions to our endeavors will be particularly important at this time as we embark on programmatic and geographic expansion of our activities.”

Continue reading